0001209191-22-027688.txt : 20220506 0001209191-22-027688.hdr.sgml : 20220506 20220506185856 ACCESSION NUMBER: 0001209191-22-027688 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220502 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leproust Emily M. CENTRAL INDEX KEY: 0001753655 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39482 FILM NUMBER: 22902797 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sema4 Holdings Corp. CENTRAL INDEX KEY: 0001818331 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 851966622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LUDLOW STREET STREET 2: NORTH TOWER, 8TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 617 780 8742 MAIL ADDRESS: STREET 1: 333 LUDLOW STREET STREET 2: NORTH TOWER, 8TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: CM Life Sciences, Inc. DATE OF NAME CHANGE: 20200715 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-05-02 2022-05-04 0 0001818331 Sema4 Holdings Corp. SMFR 0001753655 Leproust Emily M. C/O SEMA4 HOLDINGS CORP. 333 LUDLOW STREET, NORTH TOWER, 8TH FL. STAMFORD CT 06902 1 0 0 0 Stock Option 2.20 2022-05-02 4 A 0 78914 0.00 A 2032-05-01 Class A Common Stock 78914 78914 D This Form 4 amendment has been filed solely to correct the exercise price of a previously issued stock option to purchase shares of Class A Common Stock of the Issuer reported in a Form 4 filed on May 4, 2022 (the "Form 4"). The exercise price was inadvertently stated as $2.155 in the Form 4. The exercise price should have been stated as $2.20 in the Form 4. The underlying shares shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date. /s/ Daniel Clark, Attorney-in-Fact 2022-05-06